Abstract:One of the most desirable targets for HBV medications is the sodium taurocholate cotransporting polypeptide (NTCP), an entry receptor for the hepatitis B virus (HBV). N-myristoylated preS1 2–48 (Myrcludex B or Hepcludex), an NTCP-binding peptide from the large surface protein of HBV, has been developed as the first-in-class entry inhibitor. However, its relatively large molecular weight contributes to increased immunogenicity and antibody production. As a result, it is preferable to look for an NTCP-binding peptide with a smaller size. To do this, we developed a human cell surface display strategy and screened peptides based on preS1-21. PreS1-21 (genotype D) was extended by 7 random amino acids and fused with mCherry and FasL transmembrane domain. The pooled constructs were transfected into HEK293 cells by using the transposon/transposase system to create a library displaying various peptides on the cell surface with red fluorescence. On the other hand, we expressed NTCP protein fused with EGFP on HEK293 and used the membrane lysate containing NTCP-GFP as the bait protein to select peptides with increased NTCP affinity. After 7 cycles of selection, the deep sequencing results revealed that some polypeptides were more than 1,000 times enriched. Further screening of the mostly enriched 10 peptides yields the peptide preS1-21-pep3. Replacing the preS1-21 sequence of preS1-21-pep3 with those from different genotypes demonstrated that the consensus sequence of genotype A–F had the best performance. The peptide (Myr-preS1-21-pep3) was synthesized and tested on the HepG2-NTCP cell model. The results showed that Myr-preS1-21-pep3 is approximately 10 times more potent than the initial peptide Myr-preS1-21 in preventing HBV infection. In conclusion, we developed a new strategy for screening peptides binding to membrane proteins and identified a new NTCP-binding peptide with a much smaller size than Hepcludex.

Screening for PreS Specific Binding Ligands with a Phage Displayed Peptides Library

Screening of binding protein of hepatitis B virus pre-pre-s promoter by phage display technique

Selection of HBV preS1 binding penta peptides by phage display

Screening and characterization of hepatic B virus Pre-S2 binding proteins by phage display system

Identification and Characterization of Peptides That Interact with Hepatitis B Virus Via the Putative Receptor Binding Site.

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Construction of a Phage Display Library of Human Single-Chain Fv Antibodies from Peripheral Blood Lymphocytes of People with Positive Serum Antibody Against Hepatitis B Virus Core Protein

Expression and purification of the complete PreS region of hepatitis B Virus

Efficient Inhibition of Hepatitis B Virus Infection by a Pres1-Binding Peptide

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Overexpression and Identification of Hepatitis B Virus Pres Antigen in E. Coli

To Screen Binding Protein of Hepatitis B Virus Core Promoter with Phage Display Technic

Establishment of a human cell line with a surface display system for screening and optimizing Na+-taurocholate cotransporting polypeptide-binding peptides

A Virus-Like Particle of the Hepatitis B Virus Pres Antigen Elicits Robust Neutralizing Antibodies and T Cell Responses in Mice.

Biopanning of HGV epitope from a phage displayed library

A Highly Sensitive Detection System based on Proximity-dependent Hybridization with Computer-aided Affinity Maturation of a scFv Antibody

Screening of gene encoding of hepatic proteins interacting with pre-S1 transactivated protein 3 via yeast two-hybrid

Identification of the Critical Regions in Hepatitis B Virus Pres Required for Its Stability

Screening of Hepatocyte Proteins Binding to Complete S Protein of Hepatitis B Virus by Yeast-Two Hybrid System

Screening Tumor-Targeting Bacteriophage Particles by Pre-Clearing Phage Display

Screening, Expression and Characterization of a Novel Protein Binding to Hepatitis B Surface Antigen